Such results showed that EGFR was significantly (p < 0.05) correlated with FGF2 and FGFBP1 gene expression levels in all BRCA patients and significantly (p < 0.05) positively correlated with all these genes in BRCA patients. The gene discussed is FGF2; the disease is invasive breast carcinoma.